title: [Molecular methods for diagnostics and assessment of treatment effectiveness in modern pediatric hematooncology].
abstract: This paper is a review of current diagnostic applications of molecular methods in pediatric hematooncology, including analyses performed at disease presentation, evaluation of prognosis as well as those for assessment of treatment effectiveness. Here we present the examples of important fields of application of molecular methods in pediatric hematooncology, i.e. identification of clinically significant fusion genes in acute lymphoblastic leukemia and monitoring of minimal residual disease in this most frequent childhood malignancy. Moreover, we present the methodology and clinical significance of quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation. The methods presented include fluorescent in situ hybridization, reverse transcription, conventional and quantitative polymerase chain reaction, as well as methods of genotyping based on analysis of microsatellite marker polymorphism, single nucleotide polymorphism, and Indel markers.
authors.affiliation: Klinika Onkologii, Hematologii i Transplantologii Pediatrycznej, II Katedra Pediatrii, Akademia Medyczna im. Karola Marcinkowskiego w Poznaniu. ma.dawidowska@wp.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Dawidowska
authors.forename: Jacek
authors.initials: J
authors.lastname: Wachowiak
authors.forename: Michał
authors.initials: M
authors.lastname: Witt
mesh_terms: D002648:Child; D005819:Genetic Markers; D018380:Hematopoietic Stem Cell Transplantation / Q000592:standards*; D006801:Humans; D017403:In Situ Hybridization; D018365:Neoplasm, Residual / Q000235:genetics* / Q000276:immunology; D020641:Polymorphism, Single Nucleotide; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D018183:Transplantation Chimera / Q000235:genetics*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D005819:Genetic Markers